In April this year the two sides announced they had agreed to combine in an all-stock transaction. In February 2021, FSI and its subsidiary NanoChem Solutions had made a strategic investment in Lygos to advance the latter’s bio-aspartic acid technology.

NanoChem Solutions specializes in biodegradable, water-soluble products using thermal polyaspartate (TPA) biopolymers, which are made from biological amino acid, L-aspartic and have wide usage in applications such as scale inhibitors, detergent ingredients, water treatment and crop enhancement.

Lygos, founded by a team of synthetic bioengineering experts at University of California Berkeley, has developed a smart technology platform to develop sustainable organic acid specialty chemicals and bio-monomers that are designed to replace fossil-based products.

Author: Elaine Burridge, Freelance Journalist